StreetInsider.com News Articles

Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

Wed, 04 Mar 2026 09:00:00 -0500

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has earned the 2026 Gallup Exceptional Workplace Award (GEWA), marking the third consecutive year the company has received this prestigious recognition. The award honors organizations with some of the most engaged workplace cultures in the world.

Gallup recognized Exact Sciences for fostering a culture where employees feel valued and connected to the company’s mission, enabling strong performance even during periods of change and complexity.

"Our people are the heart of Exact Sciences,” said Sarah Condella, executive vice president of

Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

Wed, 04 Mar 2026 09:00:00 -0500

"Our people are the heart of Exact Sciences,” said Sarah Condella, executive vice president of

Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

Wed, 04 Mar 2026 09:00:00 -0500

"Our people are the heart of Exact Sciences,” said Sarah Condella, executive vice president of

Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

Wed, 04 Mar 2026 09:00:00 -0500

"Our people are the heart of Exact Sciences,” said Sarah Condella, executive vice president of

Form 4 EXACT SCIENCES CORP For: Feb 27 Filed by: Conroy Kevin T

Tue, 03 Mar 2026 19:17:00 -0500

si-local-file:///var/storage/secattach/20260303/26105047.html

Form 4 EXACT SCIENCES CORP For: Feb 27 Filed by: Conroy Kevin T

Tue, 03 Mar 2026 19:17:00 -0500

si-local-file:///var/storage/secattach/20260303/26105047.html

Form 4 EXACT SCIENCES CORP For: Feb 27 Filed by: Condella Sarah

Tue, 03 Mar 2026 19:16:00 -0500

si-local-file:///var/storage/secattach/20260303/26105036.html

Form 4 EXACT SCIENCES CORP For: Feb 27 Filed by: Condella Sarah

Tue, 03 Mar 2026 19:16:00 -0500

si-local-file:///var/storage/secattach/20260303/26105036.html

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

WILMINGTON, Del.--(BUSINESS WIRE)-- Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ: PRVA)-led colorectal cancer (CRC) screening program, supported by Amalgam Rx, Inc. and Exact Sciences Corp. (NASDAQ: EXAS). Documented in a published Privia Health case study, the program demonstrates how EHR-integrated workflows and proactive patient outreach supported an increase of CRC

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Tue, 03 Mar 2026 10:00:00 -0500

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

Form 4 EXACT SCIENCES CORP For: Feb 25 Filed by: Bloomer Aaron